Industry News

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned subsidiary Zecotek Imaging Systems has signed an exclusive sales and distribution agreement with RAM N.S. Technologies for Zecotek's imaging products in Israel. "Ram-Tech is very pleased to be awarded with the exclusive distribution license within Israel for..."/>
Zecotek Signs Agreement with RAM N.S. Technologies to Market and Distribute Imaging Products in Israel
Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned subsidiary Zecotek Imaging Systems has signed an exclusive sales and distribution agreement with RAM N.S. Technologies for Zecotek's imaging products in Israel. "Ram-Tech is very pleased to be awarded with the exclusive distribution license within Israel for Zecotek's..."/>
Zecotek Signs Agreement with RAM N.S. Technologies to Market and Distribute Imaging Products in Israel
Horizon Pharma plc and US-based Raptor Pharmaceutical Corp. have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued and outstanding shares of Raptor Pharmaceutical Corp. common stock for USD 9.00 per share in cash, for an implied fully diluted equity value of approximately USD 800 m, the companies said. The transaction is expected to close in 4 Q16. Horizon said the deal strengthens its focus on rare..."/>
Horizon Pharma to Acquire Rare Disease Specialist Raptor Pharmaceutical for USD 800m
Agenus Inc., Nektar Therapeutics, GlobeImmune Inc., and Anthera Pharmaceuticals Inc.. These companies belong to the Biotech industry, which is slowly gaining strength but remains down -17% YTD."/>
Research Reports Initiation on Biotech Stocks -- Agenus, Nektar Therapeutics, GlobeImmune and Anthera Pharma
UnitedHealth Group has been named to the 2016 Dow Jones Sustainability North America Index and the Dow Jones Sustainability World Index for the 18th consecutive year. UnitedHealth Group was recognized as among the leading companies worldwide for economic, environmental and social sustainability performance that supports business value and long-term financial performance. The company ranked among the highest of its peers in the Health Care Providers&..."/>
UnitedHealth Group Named to Dow Jones Sustainability North America and World Indices for 18th Consecutive Year
Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider with a select therapeutic development pipeline, today announces a new five-year strategic manufacturing services agreement under which PCT will produce SPEAR T-cell therapies for Adaptimmune Therapeutics plc. PCT, through dedicated, specialized staff and facilities, will produce the SPEAR T-cell products at its..."/>
Caladrius Subsidiary, PCT, Announces Five-Year Strategic Manufacturing Services Agreement with Adaptimmune
RTI Surgical, a surgical implant company, announced on Monday the receipt of regulatory clearance from the Australian Therapeutic Goods Administration for nanOss Bioactive bone void filler in Australia. Also, the company has received CE Mark from BSI for nanOss Bioactive Loaded bone void filler and nanOss Bioactive 3 D bone void filler in Europe. The company said NanOss Bioactive bone void filler will be distributed for RTI Surgical in Australia by LifeHealthcare Group..."/>
RTI Surgical announces receipt of regulatory clearances; Distribution of nanOss Bioactive in Australia and Europe expanded
Karolinska Development AB announces that its portfolio company BioArctic AB has entered into a strategically important collaboration with AbbVie, a global biopharmaceutical company, to develop and commercialize BioArctic's portfolio of antibodies directed against alpha-synuclein for the treatment of Parkinson's disease and other potential indications.. Parkinson's disease is the second most-common neurological disease, affecting more..."/>
Karolinska Development portfolio company BioArctic enters into Collaboration with AbbVie for Parkinson's Disease Research
Cadila Healthcare Ltd, a part of Zydus Cadila group, on Tuesday said it has partnered with Japanese drug maker Takeda Pharmaceutical Co. Ltd to develop and commercialise a vaccine against chikungunya. The broad-based agreement includes early-stage development to the final commercialisation of the vaccine. The terms of the agreement were not disclosed."/>
Zydus partners Takeda to develop, market vaccine for chikungunya [Mint, New Delhi]
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the expansion of its global footprint with the opening of a new development and commercial hub in Maidenhead, UK. In anticipation of substantial growth across Alnylam over the next five years, the office opens with a core Clinical Development, Regulatory Affairs, and Commercial team and space for an additional 100 employees. “Since our inception in..."/>
Alnylam to Expand Global Footprint with New European Office in Maidenhead, UK
AbbVie, a global biopharmaceutical company, to develop and commercialize BioArctic’ s portfolio of antibodies directed against alpha-synuclein for the treatment of Parkinson’ s disease and other potential indications. Parkinson’ s disease is the second most-common neurological disease, affecting more than 10 million people worldwide. Mutations in alpha-synuclein are..."/>
BioArctic AB: BioArctic Enters into Collaboration with AbbVie for Parkinson’s Disease Research
Bionor Pharma ASA. After the transaction Lars Høie holds 97,699,303 subscription rights. Lars Høie also holds 50,253,370 shares equivalent to 5.84% of the issued shares of the Company."/>
Bionor Pharma ASA - Mandatory notification of trade
Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today announced the pricing of an underwritten public offering of 5,350,000 shares of its common stock at a price to the public of $12.25 per share. In addition, Aquinox has granted the underwriters a 30- day option to purchase up to 802,500 additional..."/>
Aquinox Prices Public Offering of Common Stock
Glenmark Pharmaceuticals Ltd on Monday said it has entered into an agreement with US-based Particle Sciences Inc. to develop and market a generic version of Celgene Corp.' s Abraxane, used in the treatment of breast and pancreatic cancers. As per the terms of the agreement, Glenmark has obtained exclusive global marketing and distribution rights to the product upon commercialization. Particle Sciences will develop this product exclusively for Glenmark,..."/>
Glenmark, Particle Sciences ink deal to develop generic cancer drug Abraxane [Mint, New Delhi]
Profiting from new accounting standards [Mint, New Delhi]
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has completed its acquisition of FEI Company, Inc., the leader in high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion. The completion of the transaction follows the receipt of all required regulatory approvals. The business will become part of Thermo Fisher’ s Analytical Instruments Segment."/>
Thermo Fisher Scientific Completes Acquisition of FEI Company
Shire plc announced today that its wholly owned subsidiary, Shire Acquisitions Investments Ireland Designated Activity Company, priced its inaugural public offering of $12.1 billion aggregate principal amount of senior notes. The offering consists of four series of senior notes:. $3.3 billion 1.900% Senior Notes due 2019; $3.3 billion 2.400% Senior Notes due 2021; $2.5 billion 2.875% Senior Notes due 2023; and $3.0 billion 3.200% Senior Notes..."/>
Shire Prices Public Offering of Senior Notes
Cirrus Logic Inc. will replace Fairchild Semiconductor International Inc. in the S&P MidCap 400, and Amphastar Pharmaceuticals Inc. will replace Cirrus Logic in the S&P SmallCap 600 after the close of trading on Wednesday, September 21. ON Semiconductor Corp. is acquiring Fairchild Semiconductor in a deal completed today. Cirrus Logic, a fabless semiconductor company, develops, manufactures, and markets..."/>
Cirrus Logic Set to Join the S&P MidCap 400; Amphastar Pharmaceuticals to Join S&P SmallCap 600

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology670 Articles
Consumer Discretionary611 Articles
Financials443 Articles
Industrials380 Articles
Health Care380 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.